Is Ametek (AME) a risky stock?
As of July 21, 2026, Clavix grades Ametek (AME) A for risk, a composite score of 83 out of 100 on an A+ to F scale, which puts AME in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind AME's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AME scores on each, as of July 21, 2026.
What's moving AME's risk right now
Company-specific signals Clavix flags behind AME's current grade, drawn from recent news and filings as of July 21, 2026.
Wealthfront Advisers grew its AME holding by 13.4% during Q1, per its SEC disclosure. A separate 8-K filing on July 17, 2026 flagged a routine material event. Both moves are light portfolio news and don't point to a clear catalyst.
AME's FARO CREAFORM unit is adding MAX and EVO models to its HandySCAN 3D scanner line, broadening its reach across small and large parts. Analysts expect another earnings beat, and AME's precision motion parts feed into humanoid robots, though the stock trades well below its 52-week high.
What a A grade means
On the Clavix A+ to F scale, AME's composite of 83 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AME or any security. Grades are risk indicators, not predictions of return. Data may be delayed.